Research ArticleBasic Science Investigations
Quantitative Imaging of Serotonergic Biosynthesis and Degradation in the Endocrine Pancreas
Olof Eriksson, Ram K. Selvaraju, Lars Johansson, Jan W. Eriksson, Anders Sundin, Gunnar Antoni, Jens Sörensen, Barbro Eriksson and Olle Korsgren
Journal of Nuclear Medicine March 2014, 55 (3) 460-465; DOI: https://doi.org/10.2967/jnumed.113.125187
Olof Eriksson
1Department of Medicinal Chemistry, Preclinical PET Platform, Uppsala University, Uppsala, Sweden
Ram K. Selvaraju
1Department of Medicinal Chemistry, Preclinical PET Platform, Uppsala University, Uppsala, Sweden
Lars Johansson
2Department of Radiology, Oncology and Radiation Sciences, Uppsala University, Uppsala, Sweden
3AstraZeneca R&D, Mölndal, Sweden
Jan W. Eriksson
3AstraZeneca R&D, Mölndal, Sweden
4Department of Medical Sciences, Uppsala University, Uppsala, Sweden
Anders Sundin
5Department of Radiology, Karolinska University Hospital, Stockholm, Sweden; and
Gunnar Antoni
2Department of Radiology, Oncology and Radiation Sciences, Uppsala University, Uppsala, Sweden
Jens Sörensen
2Department of Radiology, Oncology and Radiation Sciences, Uppsala University, Uppsala, Sweden
Barbro Eriksson
4Department of Medical Sciences, Uppsala University, Uppsala, Sweden
Olle Korsgren
6Department of Immunology, Genetics and Pathology, Uppsala University, Uppsala, Sweden
Data supplements
Supplemental Data
Files in this Data Supplement:
In this issue
Journal of Nuclear Medicine
Vol. 55, Issue 3
March 1, 2014
Quantitative Imaging of Serotonergic Biosynthesis and Degradation in the Endocrine Pancreas
Olof Eriksson, Ram K. Selvaraju, Lars Johansson, Jan W. Eriksson, Anders Sundin, Gunnar Antoni, Jens Sörensen, Barbro Eriksson, Olle Korsgren
Journal of Nuclear Medicine Mar 2014, 55 (3) 460-465; DOI: 10.2967/jnumed.113.125187
Quantitative Imaging of Serotonergic Biosynthesis and Degradation in the Endocrine Pancreas
Olof Eriksson, Ram K. Selvaraju, Lars Johansson, Jan W. Eriksson, Anders Sundin, Gunnar Antoni, Jens Sörensen, Barbro Eriksson, Olle Korsgren
Journal of Nuclear Medicine Mar 2014, 55 (3) 460-465; DOI: 10.2967/jnumed.113.125187
Jump to section
Related Articles
Cited By...
- Longitudinal Assessment of 11C-5-Hydroxytryptophan Uptake in Pancreas After Debut of Type 1 Diabetes
- Evaluation of PET Brain Radioligands for Imaging Pancreatic {beta}-Cell Mass: Potential Utility of 11C-(+)-PHNO
- Positron Emission Tomography to Assess the Outcome of Intraportal Islet Transplantation
- Positron Emission Tomography Ligand [11C]5-Hydroxy-Tryptophan Can Be Used as a Surrogate Marker for the Human Endocrine Pancreas